A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Canadian oil exports outside of the U.S. have increased to about 6.5 per cent, up from 2.5 per cent, since May, while the ...

After years of shrinking the prominence of commercial real estate in its portfolio, M&T Bank has hit its target and begun to ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Boeing President and Chief Executive Officer Kelly Ortberg is visiting India on his first overseas trip since taking over as ...

Growth in oil, gas, and mining drives economic ambitions amid global and regional opportunities Kampala, Uganda | JULIUS ...

U.S. commercial crude oil stocks excluding the Strategic Petroleum Reserve fell by 2M barrels to 412.7 million barrels in the week ended January 10 and were ~6% below the five-year average for the ...

Palantir Technologies (NASDAQ: PLTR) went public in September 2020, and shares of the company that made its name by providing analytics and software platforms to federal government agencies have shot ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Rigel (RIGL – Research Report). The associated price target ...

Preliminary 2024 total revenue of $555 million to $560 million, exceeding top end of guidance, including Crysvita® revenue of $405 million to ...

Enbridge’s Line 5 pipeline carries 540,000 barrels of light crude oil, light synthetic crude and natural gas liquids a day ...